REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/03/2026
Voltar para busca
Dado oficial do USPTO
SEMFRENA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
10/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
08/06/2020
Data de registro
09/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/03/2021
Última transação
10/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
BUTLER, MIDGE
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
05/07/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/06/2021
FIMP
FINAL DISPOSITION PROCESSED
16/06/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/12/2020
PUBO
PUBLISHED FOR OPPOSITION
22/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/11/2020
RFNT
REFUSAL PROCESSED BY IB
04/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/09/2020
RFRR
REFUSAL PROCESSED BY MPU
16/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/08/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
25/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
25/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/08/2020
CNRT
NON-FINAL ACTION WRITTEN
17/08/2020
DOCK
ASSIGNED TO EXAMINER
17/08/2020
MAFR
APPLICATION FILING RECEIPT MAILED
04/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/07/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
30/07/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/07/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SEMFRENA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.